There’s a question as to whether these metrics actually translate into what’s actually driving quality care, explained Loren Meyer, MD, president of HCA Physician Services, during a session at the National Association of Managed Care Physicians 2019 Fall Managed Care Forum being held October 10-11 in Las Vegas, Nevada.
It’s no secret that physicians are spread thin trying to deliver care. In addition to the traditional role of caring for their patients, there has more recently been the addition of measuring quality outcomes.
And, there’s question as to whether these metrics actually translate into what’s actually driving quality care, explained Loren Meyer, MD, president of HCA Physician Services, during a session at the National Association of Managed Care Physicians 2019 Fall Managed Care Forum being held October 10-11 in Las Vegas, Nevada.
For example, said Meyer, the Healthcare Effectiveness Data and Information Set, which is implemented by the National Committee for Quality Assurance, is a tool used by more than 90% of insurers to measure performance. The set, which includes 81 measures across 5 domains of care, are meant to compare health plan performances but are now being used to compare practices, and many of these measures may not be applicable, according to Meyer.
“We know at the macro level that we have a lot of opportunity, but for me the question comes back down to what’s going on at the local level?” said Meyer, explaining that it’s essential to know how providers are responding and adapting to these quality measures.
In order to find out just that, HCA Physician Services constructed a survey through Survey Monkey in June that surveyed employed physicians across markets in 7 states—Colorado, Florida, Kansas, Louisiana, Montana, Minnesota, and New Hampshire.
There were 132 responses—a 24% response rate—consisting of primary care providers, medical subspecialists, and surgical specialists. Of the responses, the majority came from primary care providers, followed by surgical specialists and then medical specialists. The majority of respondents had been in practice for more than 20 years.
The survey revealed that physicians are pretty interested in achieving high-level performance on clinical quality metrics. On a scale of 1-10, there was an interest level of 7. Digging deeper, the survey asked respondents to rank 4 drivers of interest from the most influential to least influential. Driving high quality care was the main catalyst, the researchers found.
“They believe in metrics, they understand the relationship between what’s being measured to and the care of their patient population,” said Meyer, reflecting on the results.
Meanwhile, the other 3 drivers—desire to excel on metrics associated with my practice, reducing national healthcare expenditures, and personal financial incentives—had mixed rankings.
Interestingly, nearly 60% of respondents said that staffing was not a barrier to achieving high-level performance. But when asked what roles they would need additional staff to fill, the majority identified a need for staff to support documentation and coding as the most important, followed bythe category of "other", outreach to patients to help close care gaps, and to identify care gaps.
Another notable finding from the survey was that just over half of respondents said that less than 25% of their compensation would need to be affected to increase their motivation for achieving high-level performance. Meanwhile, just over 30% said 25% to 50% of their compensation would need to be impacted. Less than 10% indicated than more than 75% of their compensation would need to be impacted.
There was no majority vote on how much of the patient population would need to be in value-based reimbursement programs for an increased motivation; just over 40% said 26% to 50% would need to be involved, approximately 28% said that less than 25% would need to be involved, approximately 22% said 51% to 75% would need to be involved, and 10% said that more than 75% of patients would need to be involved.
There was one comment that Meyer highlighted, which read, “I don't think metrics always capture meaningful data on patient outcomes. Everyone games the system to do better, so not sure any data captures true information either. [W]e all want to do better and would welcome a real analysis of how we are doing with feedback of how to improve.”
The question is now what are we going to do about it, asked Meyer. From a provider perspective there needs to be:
There are also opportunities for improvement amongst payer organizations, including:
“What really comes together for this is we need to figure out, even with predominantly fee-for-service world, how are payer and provider organizations, operationally and clinically, going to work together to support physicians?” said Meyer.
If we don’t make it easier for them to do the right thing, we’ll continue to struggle, he added.
Could On-Body Delivery of Isatuximab Bring More Competition to Anti-CD38 Myeloma Treatment?
June 6th 2025Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration. Patients overwhelmingly preferred the hands-free delivery option.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Zanubrutinib Shows Durable Benefit for High-Risk CLL/SLL at 5 Years in SEQUOIA Trial
June 6th 2025Zanubrutinib showed long-term efficacy in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and deletion of the 17p chromosome, with progression-free survival similar to patients without high-risk disease characteristics.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Real-World Data Support Luspatercept vs ESAs for Anemia in Lower-Risk MDS
June 5th 2025Patients with myelodysplastic syndrome (MDS) who received luspatercept showed greater hemoglobin gains and transfusion independence compared with erythropoiesis-stimulating agents (ESAs) in a real-world analysis.
Read More
At EHA 2025, Hematology Discussions Will Stretch Across Lifespans and Locations
June 5th 2025The 2025 European Hematology Association (EHA) Congress, convening virtually and in Milan, Italy, from June 12 to June 15, 2025, will feature a revamped program structure for the meeting’s 30th anniversary while maintaining ample opportunities to network, debate, and absorb practice-changing findings in hematology and oncology.
Read More